Csenge Advisory Group’s Citius Pharmaceuticals CTXR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-600
| Closed | -$5.51K | – | 707 |
|
|
2024
Q3 | $5.51K | Hold |
600
| – | – | ﹤0.01% | 705 |
|
|
2024
Q2 | $8.76K | Hold |
600
| – | – | ﹤0.01% | 662 |
|
|
2024
Q1 | $13.5K | Hold |
600
| – | – | ﹤0.01% | 704 |
|
|
2023
Q4 | $11.3K | Hold |
600
| – | – | ﹤0.01% | 658 |
|
|
2023
Q3 | $10.3K | Hold |
600
| – | – | ﹤0.01% | 634 |
|
|
2023
Q2 | $18K | Hold |
600
| – | – | ﹤0.01% | 652 |
|
|
2023
Q1 | $17.6K | Hold |
600
| – | – | ﹤0.01% | 592 |
|
|
2022
Q4 | $11.9K | Hold |
600
| – | – | ﹤0.01% | 595 |
|
|
2022
Q3 | $18K | Hold |
600
| – | – | ﹤0.01% | 606 |
|
|
2022
Q2 | $14K | Buy |
+600
| New | +$14K | ﹤0.01% | 566 |
|